These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11951863

  • 21. [Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
    Karlsen FM, Kamper AL.
    Ugeskr Laeger; 2003 Oct 13; 165(42):4006-9. PubMed ID: 14610833
    [No Abstract] [Full Text] [Related]

  • 22. Valsartan in chronic heart failure.
    Ripley TL.
    Ann Pharmacother; 2005 Mar 13; 39(3):460-9. PubMed ID: 15687480
    [Abstract] [Full Text] [Related]

  • 23. [ACE inhibitors and/or sartans in heart failure: is there a difference?].
    Vachiéry JL.
    Rev Med Brux; 2003 Sep 13; 24(4):A249-52. PubMed ID: 14606288
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.
    De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, Francolini G, Bertocchi F, Ferrari R, Rizzon P, Pitzalis MV.
    Am Heart J; 2003 Nov 13; 146(5):E17. PubMed ID: 14597946
    [Abstract] [Full Text] [Related]

  • 25. Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
    Cohn JN.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun 13; 1(2 Suppl):S38-40. PubMed ID: 17199220
    [Abstract] [Full Text] [Related]

  • 26. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
    Hollenberg NK.
    Curr Hypertens Rep; 2002 Dec 13; 4(6):411; discussion 412. PubMed ID: 12462208
    [No Abstract] [Full Text] [Related]

  • 27. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep 05; 144(35-36):57. PubMed ID: 12380364
    [No Abstract] [Full Text] [Related]

  • 30. [Heart failure. Who benefits from an AT1 blocker?].
    MMW Fortschr Med; 2001 Nov 22; 143(47):62. PubMed ID: 11791370
    [No Abstract] [Full Text] [Related]

  • 31. [Heart failure. With the AT1-blocker less frequent rehospitalization].
    MMW Fortschr Med; 2001 May 17; 143(20):65. PubMed ID: 11400619
    [No Abstract] [Full Text] [Related]

  • 32. Lessons learned from the valsartan- heart failure trial (Val-HeFT): angiotensin receptor blockers in heart failure.
    Cohn JN.
    Am J Cardiol; 2002 Nov 01; 90(9):992-3. PubMed ID: 12398968
    [No Abstract] [Full Text] [Related]

  • 33. Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study.
    Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C.
    Eur J Heart Fail; 2013 Nov 01; 15(11):1236-44. PubMed ID: 23787721
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
    Andersen NH, Mogensen CE.
    J Renin Angiotensin Aldosterone Syst; 2001 Sep 01; 2(3):146-52. PubMed ID: 11881115
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):726-33. PubMed ID: 16487836
    [Abstract] [Full Text] [Related]

  • 38. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
    Cohn JN.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 21; 4(3):137-9. PubMed ID: 14608516
    [Abstract] [Full Text] [Related]

  • 39. [ESC guidelines for therapy of heart failure. AT1 blockers are now also included].
    MMW Fortschr Med; 2002 Jan 24; 144(3-4):62. PubMed ID: 11862800
    [No Abstract] [Full Text] [Related]

  • 40. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
    Miller AB, Srivastava P.
    Cardiol Clin; 2001 May 24; 19(2):195-202, v. PubMed ID: 11407105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.